Axa
BNTX icon

Axa’s BioNTech BNTX Stock Holding History

Axa’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-94,032
Closed -$8.56M – 1127
2025
Q1 		$8.56M Sell
94,032
-118
-0.1% -$13.2K 0.03% 413
2024
Q4 		$10.7M Sell
94,150
-149
-0.2% -$17K 0.03% 363
2024
Q3 		$11.2M Buy
94,299
+26
+0% +$2.39K 0.03% 376
2024
Q2 		$7.58M Sell
94,273
-74,713
-44% -$6.83M 0.02% 442
2024
Q1 		$15.6M Sell
168,986
-9,886
-6% -$948K 0.05% 323
2023
Q4 		$18.9M Sell
178,872
-19,886
-10% -$2M 0.06% 284
2023
Q3 		$21.6M Sell
198,758
-4,177
-2% -$462K 0.08% 260
2023
Q2 		$21.9M Buy
202,935
+18,940
+10% +$2.13M 0.07% 275
2023
Q1 		$22.9M Buy
183,995
+115,715
+169% +$15.9M 0.08% 272
2022
Q4 		$10.3M Buy
+68,280
New +$10.5M 0.04% 433
2020
Q4 		– Sell
-3,100
Closed -$215K – 1266
2020
Q3 		$215K Buy
+3,100
New +$222K ﹤0.01% 1147

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Axa's BNTX Position: Q2 2025 in Review

Axa sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 94,032 shares — an estimated $8.56M sold.

Axa first reported a position in BNTX in Q3 2020 and held it in 11 quarters. The position peaked at $22.9M in Q1 2023. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Axa reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Axa sold 94,032 BioNTech shares in Q2 2025, an estimated $8.56M.
  • Axa first reported a position in BioNTech in Q3 2020 and held it in 11 quarters.
  • Axa's BioNTech position peaked at $22.9M in Q1 2023.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Axa's 13F filing for Q2 2025, filed 14 Aug 2025.